Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: A systematic review and meta-analysis

European Journal of Cancer

Volumn 49, Issue 4, 2013, Pages 812-825

  Glechner, Anna ^a   Wöckel, Achim ^c   Gartlehner, Gerald ^a,b   Thaler, Kylie ^a   Strobelberger, Michaela ^a   Griebler, Ursula ^a   Kreienberg, Rolf ^c  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Axilla surgery; Breast neoplasms; Disease free survival; Lymph node excision; Lymphatic metastasis; Meta analysis; Neoplasm recurrence; Sentinel lymph node biopsy; Survival analysis; Systematic review

Indexed keywords

AXILLARY LYMPH NODE; AXILLARY LYMPH NODE EXTIRPATION; BREAST CANCER; CANCER SURVIVAL; COMPARATIVE STUDY; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; LYMPHEDEMA; META ANALYSIS; OVERALL SURVIVAL; PARESTHESIA; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE DISSECTION; SURGICAL INFECTION; SYSTEMATIC REVIEW;

EID: 84873722999     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.010     Document Type: Article

References (39)

1. C. Mathers, T. Boerma, and D. Mafat The global burden of disease: 2004 update 2008 World Health Organization Geneva
2. J. Ferlay, D.M. Parkin, and E. Steliarova-Foucher Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 4 2010 765 781 [epub 2010/02/02]
3. A. Johnson, and J. Shekhdar Breast cancer incidence: what do the figures mean? J Eval Clin Pract 11 1 2005 27 31 [epub 2005/01/22]
4. K. Hemminki, R. Rawal, and J.L. Bermejo Mammographic screening is dramatically changing age-incidence data for breast cancer J Clin Oncol 22 22 2004 4652 4653 [epub 2004/11/16]
5. U.S. Albert, M. Kalder, and H. Schulte The population-based mammography screening programme in Germany: uptake and first experiences of women in 10 federal States Gesundheitswesen 74 2 2012 61 70 [epub 2011/01/14. Das populations bezogene Mammografie-Screening-Programme in Deutschland: Inanspruchnahme und erste Erfahrungen von Frauen in 10 Bundeslandern]
6. New Zealand Guidelines Group. Management of early breast cancer. New Zealand Ministry of Health 2009.
7. National Collaborating Centre for Cancer. Early and locally advanced breast cancer: diagnosis and treatment National Institute for Health and Clinical Excellence guideline 2009. 2009 Apr. Report No.: 0936-6555 (Print) 0936-6555 (Linking), Contract No.: 3.
8. J.Y. Wo, K. Chen, B.A. Neville, N.U. Lin, and R.S. Punglia Effect of very small tumor size on cancer-specific mortality in node-positive breast cancer J Clin Oncol 29 19 2011 2619 2627 [epub 2011/05/25]
9. L. Tafra, D.R. Lannin, and M.S. Swanson Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye Ann Surg 233 1 2001 51 59 [epub 2001/01/05]
10. T. Kuehn, F.D. Vogl, and G. Helms Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial Eur J Surg Oncol 30 3 2004 252 259 [epub 2004/03/19]
11. L. Bergkvist, J. Frisell, and G. Liljegren Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer Br J Surg 88 12 2001 1644 1648 [epub 2001/12/12]
12. T. Kim, A.E. Giuliano, and G.H. Lyman Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis Cancer 106 1 2006 4 16 [epub 2005/12/06]
13. Scottish Intercollegiate Guidelines Network (SIGN). Management of breast cancer in women. A national clinical guideline; 2005.
14. Brackstone M, Tey R, reviewers. Toronto (ON): Cancer Care Ontario; 2011 Sep 15 [Endorsed 2010 Nov 19]. Program in Evidence-based Care Evidence-Based Series No.: 1-1 Version 3.
15. A.E. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 3 2010 426 432 [discussion 32-33]
16. A.E. Giuliano, K.K. Hunt, and K.V. Ballman Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial JAMA 305 6 2011 569 575 [epub 2011/02/10]
17. A. Lucci, L.M. McCall, and P.D. Beitsch Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011 J Clin Oncol 25 24 2007 3657 3663 [epub 2007/05/09]
18. I. Jatoi Axillary vs sentinel lymph node dissection for invasive breast cancer JAMA 305 22 2011 2288 [author reply 90-91. Epub 2011/06/07.]
19. I.C. Chen, C.H. Lin, and Y.S. Lu Axillary vs sentinel lymph node dissection for invasive breast cancer JAMA 305 22 2011 2288 2289 [author reply 90-91. epub 2011/06/07]
20. G.W. Carlson, and W.C. Wood Management of axillary lymph node metastasis in breast cancer: making progress JAMA 305 6 2011 606 607
21. P.A. Wright, and M.E. Zenilman Less may be better: axillary dissection is unnecessary in some patients with a positive sentinel lymph node Arch Surg 146 8 2011 980 982
22. O. Zoras, D. Ziogas, and D.H. Roukos Omitting axilla lymphadenectomy even by positive sentinel lymph node: a change in breast cancer treatment practice Womens Health (Lond Engl) 7 4 2011 417 418
23. A.L. Chapman, L.C. Morgan, and G. Gartlehner Semi-automating the manual literature search for systematic reviews increases efficiency Health Info Libr J 27 1 2010 22 27
24. Higgins JP, Green S. Cochrane Handbook for systematic reviews of interventions. Handbook is 5.1.0 2011.
25. J.J. Deeks, J. Dinnes, and R. D'Amico Evaluating non-randomised intervention studies Health Technol Assess 7 27 2003 1234 iii-x, 1-173 [epub 2003/09/23]
26. B.J. Shea, C. Hamel, and G.A. Wells AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews J Clin Epidemiol 62 10 2009 1013 1020 [epub 2009/02/24]
27. G.H. Guyatt, A.D. Oxman, and G.E. Vist GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 7650 2008 924 926 [epub 2008/04/26]
28. K.Y. Bilimoria, D.J. Bentrem, and N.M. Hansen Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer J Clin Oncol 27 18 2009 2946 2953 [epub 2009/04/15]
29. M. Yi, S.H. Giordano, and F. Meric-Bernstam Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database Ann Surg Oncol 17 Suppl. 3 2010 343 351 [epub 2010/10/01]
30. M.R. Kell, J.P. Burke, M. Barry, and M. Morrow Outcome of axillary staging in early breast cancer: a meta-analysis Breast Cancer Res Treat 120 2 2010 441 447 [epub 2010/01/12]
31. T.S. Dabakuyo, J. Fraisse, and S. Causeret A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection Ann Oncol 20 8 2009 1352 1361 [epub 2009/05/27]
32. J.J. Chen, X.Y. Huang, and Z.B. Liu Sentinel node biopsy and quality of life measures in a Chinese population Eur J Surg Oncol 35 9 2009 921 927 [epub 2009/02/24]
33. J. Kootstra, J.E. Hoekstra-Weebers, and H. Rietman Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study Ann Surg Oncol 15 9 2008 2533 2541 [epub 2008/07/04]
34. A. Fleissig, L.J. Fallowfield, and C.I. Langridge Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer Breast Cancer Res Treat 95 3 2006 279 293 [epub 2005/09/16]
35. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial J Natl Cancer Inst 98 9 2006 599 609
36. I. Jatoi, B.E. Chen, W.F. Anderson, and P.S. Rosenberg Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis J Clin Oncol 25 13 2007 1683 1690 [epub 2007/04/04]
37. K.J. Van Zee, D.M. Manasseh, and J.L. Bevilacqua A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy Ann Surg Oncol 10 10 2003 1140 1151 [epub 2003/12/05]
38. B.J. van Wely, S. Teerenstra, and D.A. Schinagl Systematic review of the effect of external beam radiation therapy to the breast on axillary recurrence after negative sentinel lymph node biopsy Br J Surg 98 3 2011 326 333 [epub 2011/01/22]
39. S. Zackrisson, I. Andersson, L. Janzon, J. Manjer, and J.P. Garne Rate of over-diagnosis of breast cancer 15 years after end of Malmo mammographic screening trial: follow-up study BMJ 332 7543 2006 689 692 [epub 2006/03/07]